- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07299708
Effects of Sleep Quality, Anxiety, and Digital Behavior on Labor Progression in Term Primiparous Women: A Prospective Observational Study (SAD-LABOR)
This prospective observational study evaluates whether maternal sleep quality, anxiety levels, and nighttime digital behavior are associated with labor progression among term primiparous women. Sleep quality and anxiety are assessed before the onset of labor during routine antenatal visits using validated instruments, including the Pittsburgh Sleep Quality Index (PSQI) and the Beck Anxiety Inventory (BAI). Nighttime digital behavior characteristics, such as screen exposure and smartphone use prior to sleep, are recorded through standardized antenatal interviews.
Labor outcomes, including the duration of the latent, active, and second stages of labor, requirement for oxytocin augmentation, use of analgesia, and mode of delivery, are prospectively documented from hospital admission until birth. By examining behavioral and psychological factors prior to labor onset, the study aims to determine whether poor sleep quality, increased anxiety, or irregular nighttime digital activity are associated with prolonged labor phases or greater need for obstetric interventions.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This prospective observational cohort study investigates the influence of maternal sleep quality, anxiety levels, and nighttime digital device use on labor progression among term primiparous women. Eligible participants were term primiparous women attending routine antenatal follow-up at Izmir Tepecik Training and Research Hospital. All psychosocial assessments were completed prior to the onset of labor. Sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI), and anxiety levels were assessed using the Beck Anxiety Inventory (BAI). Nighttime digital behavior characteristics were documented through structured antenatal interviews and included pre-sleep screen exposure, smartphone use in bed, frequency of nighttime phone checking, and the type of digital content viewed before sleep.
Participants were subsequently followed through spontaneous labor, and labor-related data were collected prospectively. Initial labor characteristics documented at hospital admission included cervical dilation, contraction pattern, and overall clinical presentation. Additional labor outcomes, including the duration of the latent, active, and second stages of labor, use of oxytocin augmentation, requirement for epidural or opioid analgesia, operative vaginal delivery, cesarean delivery, and neonatal outcomes, were recorded systematically according to standardized institutional protocols.
The primary aim of the study is to determine whether poor sleep quality, elevated anxiety levels, or increased nighttime digital device use are associated with prolonged labor or dysfunctional labor patterns. Secondary aims include examining whether interactions between digital behavior variables and psychological factors contribute to variations in maternal labor physiology or to increased obstetric intervention rates.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Izmir, Turkey (Türkiye), 35020
- Tepecik Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Pregnant women at ≥ 37 weeks of gestation
- Completion of PSQI (sleep quality) and BAI (anxiety) assessments during antenatal clinic visit
- Singleton pregnancy
- Cephalic presentation
- Age 18 to 50 years
- Planning to deliver at the study hospital
- Able to provide informed consent
Exclusion Criteria:
- Multiple pregnancy
- Non-cephalic presentation
- Delivery occurring at another hospital or birth center
- Elective planned cesarean delivery
- Major fetal anomaly
- Placenta previa or placenta accreta spectrum
- Preeclampsia, eclampsia, HELLP syndrome
- Gestational diabetes requiring insulin
- Chronic medical disorders affecting labor physiology
- Use of sedative, hypnotic, or psychotropic medications
- Inability to complete questionnaires
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Primiparous Cohort
Term primiparous women assessed for sleep quality, anxiety, digital behavior, and followed through spontaneous labor.
|
Observational study with no assigned treatment or intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of Active Labor
Time Frame: From onset of active labor (≥4 cm) until full cervical dilatation (10 cm), typically within 2 to 12 hours.
|
Time in minutes from the onset of active labor (defined as cervical dilatation of ≥4 cm with regular contractions) to full cervical dilatation (10 cm).
Data will be obtained prospectively from electronic delivery records.
|
From onset of active labor (≥4 cm) until full cervical dilatation (10 cm), typically within 2 to 12 hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of Latent Phase of Labor
Time Frame: From onset of regular contractions until onset of active labor (≥4 cm), typically lasting up to 20 hours.
|
Time (in minutes) from onset of regular contractions to 4 cm cervical dilation, recorded prospectively from labor charts.
Evaluated in relation to sleep quality, anxiety levels, and nighttime digital behavior.
|
From onset of regular contractions until onset of active labor (≥4 cm), typically lasting up to 20 hours.
|
|
Duration of Second Stage of Labor
Time Frame: From full dilatation (10 cm) until birth, typically lasting up to 3 hours.
|
Time in minutes from full cervical dilatation (10 cm) to the delivery of the neonate.
Pushing time will be recorded prospectively.
|
From full dilatation (10 cm) until birth, typically lasting up to 3 hours.
|
|
Oxytocin Augmentation Requirement
Time Frame: From admission in active labor (≥4 cm) until delivery, typically within 2 to 12 hours.
|
Proportion of participants requiring oxytocin infusion due to inadequate uterine contractions or labor arrest, as documented by obstetric staff.
|
From admission in active labor (≥4 cm) until delivery, typically within 2 to 12 hours.
|
|
Mode of Delivery
Time Frame: Assessed at delivery.
|
Rates of spontaneous vaginal delivery, operative vaginal delivery, and cesarean delivery, evaluated according to sleep, anxiety, and digital behavior parameters.
|
Assessed at delivery.
|
|
Use of Epidural Analgesia
Time Frame: From onset of active labor (≥4 cm) until delivery, typically within 2 to 12 hours.
|
Proportion of participants receiving epidural anesthesia for labor pain management, and its association with sleep quality, anxiety scores, and digital device use.
|
From onset of active labor (≥4 cm) until delivery, typically within 2 to 12 hours.
|
|
APGAR Score at 1 and 5 Minutes
Time Frame: Assessed at 1 and 5 minutes after birth.
|
Apgar scores assessed at 1 and 5 minutes after birth.
|
Assessed at 1 and 5 minutes after birth.
|
|
Neonatal Intensive Care Unit (NICU) Admission
Time Frame: Assessed within the first 24 hours after birth.
|
Number of neonates requiring admission to the neonatal intensive care unit.
|
Assessed within the first 24 hours after birth.
|
|
Birth Weight
Time Frame: Assessed at birth.
|
Neonatal birth weight measured in grams immediately after delivery.
|
Assessed at birth.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TEPECIK-SAD-LABOR
- TEPECIK-EC-2025-07-10 (06/08/2 (Registry Identifier: İzmir Tepecik Training and Research Hospital Ethics Committee)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Kafrelsheikh UniversityNot yet recruitingEctopic PregnancyEgypt
-
Meir Medical CenterRecruiting
-
Bagcilar Training and Research HospitalRecruitingEctopic PregnancyTurkey (Türkiye)
-
MELISA Institute Genomics & Proteomics Research...RecruitingHealthy | Pregnancy | Early Pregnancy | Early Pregnancy Loss | ChildbirthChile
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Turku University HospitalUniversity of TurkuCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
Clinical Trials on No Intervention: Observational Cohort
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
Institut Cancerologie de l'OuestNot yet recruiting
-
University of CalgaryRecruiting
-
Guangzhou Women and Children's Medical CenterNot yet recruitingNEC - Necrotizing Enterocolitis
-
Centre Leon BerardNutricia, Inc.Not yet recruitingSmell Disorder | Taste Alterations | Eating Behavior ChangesFrance
-
Trakya UniversityRecruitingFrailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture SurgeryFrailty | Hip Fracture | Proximal Femur FractureTurkey (Türkiye)
-
Washington University School of MedicineVanderbilt University Medical Center; University of Abuja Teaching HospitalNot yet recruitingPreeclampsia (PE) | Cardiovascular Biomarkers | Preeclampsia (PE) RiskNigeria
-
Heinrich-Heine University, DuesseldorfRoche Pharma AG; Maria Hilf Clinics GmbH, Mönchengladbach; German Multiple Sclerosis...RecruitingMultiple Sclerosis | Fatigue Syndrome, Chronic | Sleep Disorders | Primary Progressive Multiple Sclerosis | Secondary Progress Multiple Sclerosis | Remitting-Relapsing Multiple SclerosisGermany
-
Instituto de Investigación Sanitaria de la Fundación...Hospital General Universitario Gregorio Marañon; Fundació d'investigació Sanitària... and other collaboratorsRecruiting
-
The First Hospital of Jilin UniversityNot yet recruitingCritical Illness | Adult | ICU